May 30, 2020
Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
May 06, 2020
Novartis announces FDA approval of MET inhibitor Tabrecta(TM) for metastatic non-small cell lung cancer with METex14
Apr 28, 2020
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight
Jan 21, 2020
LUNGevity and the ALK Positive Group Partner to Fund $1 Million in Lung Cancer Research Awards
Dec 11, 2019
Lilly Opens First Ever Randomized Phase 3 Clinical Trial in Treatment-Naïve RET Fusion-Positive Non-Small Cell Lung Cancer
Sep 25, 2019
Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications
Sep 09, 2019
Lilly Announces Positive Results for Selpercatinib (LOXO-292), Demonstrating a 68 Percent Objective Response Rate and Sustained Durability in Heavily Pretreated RET Fusion-Positive Non-Small Cell Lung Cancer
Aug 21, 2019
CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody
May 28, 2019
Roche launches first in vitro diagnostic IHC test to detect ROS1 protein in cancers
May 21, 2019
The anaplastic lymphoma kinase (ALK) inhibitors market will register a CAGR of about 21% by 2023
Jan 24, 2019
Remote Participation Enables Patients with ALK-Positive Lung Cancer from Across the Country to Participate in New Study of Treatment Resistance
Jan 04, 2019
Blueprint Medicines Announces "2020 Blueprint" Global Business Strategy and Outlines Key Corporate Goals
Nov 27, 2018
Roche launches first IVD pan-TRK immunohistochemistry assay
Oct 17, 2018
Thermo Fisher Scientific CE Marks Oncomine Dx Target Test
Sep 19, 2018
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment for Patients with NSCLC at Annual Meeting of the Chinese Society of Clinical Oncology
Sep 10, 2018
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer
Jun 22, 2018
ALK and ROS1 Clones from CST Featured in Latest Guidelines for the Diagnosis and Treatment of Non-Small Cell Lung Cancer
Jun 04, 2018
First-Ever Scientific Research Awards Funded by ALK Positive in Partnership with LUNGevity Foundation
May 29, 2018
FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
May 22, 2018
New Review Highlights the Latest Developments in Pediatric Anaplastic Large Cell Lymphoma